Pre-Market Stock Notes (FEB 22, 2007)

(BA) Boeing won a 4-plane order from British Air for its 777 jets.
(CHE) Chemed $0.73 EPS vs $0.57e; unsure if comparable.
(CLRT) Clarient receives new patent covering rare cell detection.
(CROX) Crocs trading up 2% pre-market after beating earnings and raising guidance.
(DELL) Dell disclosed that Rollins’ exit package would reach $5M.
(DMGI) Digital Music Group announced long-term digital distribution agreements with 3 independent record labels.
(EFD) eFunds $0.41 EPS vs $0.41e.
(FNM) Fannie Mae rejected some old bonuses totaling $44 million after the accounting scandals.
(FTD) FTD Group announced 6M share buyback plus $0.1625 cash dividend.
(HPQ) Hewlett Packard fell 1% after-hours after beating earnings and raising guidance, mainly because the degree of the beats and raises are not what they were after the 100%+ move over the last 2 years. 
(HSIC) Henry Schein $0.70 EPS vs $0.67e.
(JBLU) JetBlue revised earnings lower after spate of cancellations, although this was already telegraphed yesterday.
(JBX) Jack in the Box $1.03 EPS vs $0.81e; allocates 3.3 million shares for repurchase this year; guides next quarter $0.67-0.70 and fiscal year $3.27-3.33 versus $0.69 and $3.10 estimates.
(MDT) Medtronic fell 3.5% in after-hours trading after profits up 6% but defibrillator sales fell 10%.
(MHS) Medco $0.84 EPS outside of items versus $0.79e; raised 2007 outlook; raised buyback plan by $3 Billion.
(MRK) Merck has dropped its lobbying efforts to make Gardasil ®; CFO retiring in July. 
(MT) Arcelor Mittal said profit fell 3.5% in 2006 but will return $2.4 Billion to holders via dividend and share buybacks.
(NFI) Novastar lost 25% after-hours after showing losses and saying it would see continued pressures and may change its REIT status.
(NICE) Nice Systems $0.37 EPS vs -$0.34e; earnings down 38% from last year; stock up 1%.
(NTBK) NetBank -$1.86 EPS vs -$1.06e; sees losses at lower-end of of a -$0.08 to -$0.24 with downside risks; claims to have completes restructurings.
(PCYC) Pharmacyclics trading down 40% after receiving a ‘refuse to file’ letter on Xcytrin for patients with non-small cell lung cancer patients with brain metastases.
(RNT) Aaron Rents $0.35 EPS vs $0.34e.
(THRX) Theravance’s Telavancin NDA accepted by FDA, company receives $31 million milestone.
(UTX) United Tech gets roughly $275 million in elevator monopoly cartel fines in EU along 4 EU-based elevator companies.
(WBMD) WebMD set to report earnings.
(WFMI) Whole Foods set to report earnings.
(ZLC) Zale’s $1.80 EPS vs $1.89e.

Jon C. Ogg
February 21, 2007